Skip to main content
. Author manuscript; available in PMC: 2009 Aug 1.
Published in final edited form as: J Thromb Haemost. 2008 May 22;6(8):1413–1421. doi: 10.1111/j.1538-7836.2008.03034.x

Fig. 3.

Fig. 3

Complement activation by CS in the fluid phase. Platelet-poor plasma (PPP) was incubated with increasing concentrations of chondroitin sulfate (CS) for 30 min at 37 °C, and the generation of C3a (A) and sC5b-9 (B) in PPP (diamonds), without additives and in the presence of 10 mm EDTA (triangles) or 10 mm Mg2+-EGTA (squares), was measured by enzyme-linked immunosorbent assay (ELISA). CS (25 μg mL−1) and supernatants from isolated and thrombin receptor-activating peptide-activated platelets (PS) were treated with 5 U of chondroitinase ABC (CSE) for 5 h at 37 °C, and then incubated with PPP for 30 min at 37 °C (white bars). In the same experiments, CS and PS were incubated in PPP in the absence (black bars) or presence (gray bars) of 10 mm Mg2+-EGTA. The generation of C3a (C) and sC5b-9 (D) was analyzed by ELISA. Data are mean ± SEM (n = 3). AU, arbitrary units.